In a 56-year-old woman with a history of polycystic kidney disease, hypertension, and a kidney transplant two years ago (on tacrolimus, prednisone, and mycophenolate), who presents with a 4 mm hard red nodule with ulceration on the left side of the nose persisting for six months, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Squamous Cell Carcinoma

The most likely diagnosis is squamous cell carcinoma (SCC). This patient's presentation of a persistent, non-healing, hard, ulcerated nodule on a sun-exposed area (nose) in the setting of chronic immunosuppression following kidney transplantation is classic for cutaneous SCC.

Clinical Reasoning

Why SCC is Most Likely

The key diagnostic features pointing to SCC include:

  • Chronic immunosuppression: She is on triple immunosuppressive therapy (tacrolimus, prednisone, mycophenolate) for 2 years post-transplant 11
  • Classic lesion characteristics: 4 mm hard red nodule with ulceration
  • Location: Sun-exposed area (nose) - a high-risk anatomic site
  • Duration: 6-month persistence indicates aggressive behavior
  • Patient population: Organ transplant recipients (OTRs) have dramatically increased risk of cutaneous SCC

Evidence from Immunosuppression

Organ transplant recipients on maintenance immunosuppression face substantially elevated skin cancer risk 2. The patient's specific regimen includes:

  • Tacrolimus (calcineurin inhibitor): Associated with increased malignancy risk 1
  • Mycophenolate mofetil: Part of standard maintenance therapy
  • Prednisone: Corticosteroid component

Older immunosuppressive agents like azathioprine and ciclosporin carry higher SCC risk, but all immunosuppressive regimens increase cutaneous malignancy susceptibility 2.

Why Other Diagnoses Are Less Likely

Actinic keratosis: Typically presents as rough, scaly patches rather than hard nodules with ulceration; represents pre-malignant rather than invasive disease.

Furuncle: Would be an acute infection (days to weeks), not a 6-month persistent lesion; would be tender and fluctuant, not hard.

Melanoma: While immunosuppressed patients have increased melanoma risk, the description of a "red nodule" is atypical; melanoma usually presents with pigmentation changes.

Molluscum contagiosum: Can occur in immunosuppressed patients 1, but presents as umbilicated papules, not hard ulcerated nodules; typically multiple lesions.

Critical Next Steps

Immediate biopsy is mandatory - this cannot be observed or treated empirically. The 6-month duration already represents concerning delay.

Biopsy Considerations

  • Full-thickness punch or excisional biopsy preferred
  • Must differentiate SCC from opportunistic infections that can mimic malignancy in transplant recipients 345
  • Histopathology will confirm diagnosis and guide management

Important Caveats

Do not dismiss atypical presentations: While SCC is most likely, immunosuppressed patients can develop unusual opportunistic infections presenting as nodules:

  • Fungal infections (Aspergillus, Scedosporium, Histoplasma) can mimic skin malignancies 345
  • These require tissue diagnosis with special stains and cultures

Immunosuppression modification: If SCC is confirmed, consider revision of maintenance immunosuppression 2:

  • Conversion from calcineurin inhibitors to mTOR inhibitors (sirolimus, everolimus) reduces subsequent SCC risk
  • This should be coordinated with transplant nephrology to balance rejection risk

The hard, ulcerated, persistent nature of this lesion on a sun-exposed site in a chronically immunosuppressed patient makes SCC the diagnosis until proven otherwise.

References

Related Questions

How should buprenorphine be used concurrently with other opioids, including appropriate dosing, titration, and safety considerations?
What are the indications for PET-CT in a patient with Gleason 7 (3+4) prostate adenocarcinoma?
What is the most appropriate initial test for a 48-year-old man with three months of bulky, oily, pale stools, mild postprandial upper abdominal pain, recent weight loss, hypertension, hyperlipidemia on lisinopril and atorvastatin, who smokes half a pack daily and drinks about 10 cans of beer per day?
For a patient with prostate cancer diagnosed on biopsy with cancer in 2 of 7 cores, each involving about 4% of the core, Gleason score 3 + 4 (Grade Group 2), clinical stage T1c, and prostate-specific antigen below 10 ng/mL, what is the recommended management?
Which urinary‑tract infection pathogens are susceptible to ciprofloxacin but not to fosfomycin?
For a 32-year-old male veteran with PTSD and a history of substance‑use disorder in remission who presents with worsening insomnia, irritability, and difficulty concentrating after his medication ran out, which pharmacologic agent should be initiated to most effectively relieve his symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.